Optimal Chemotherapy for Women With Breast Cancer: The Plot Thickens-Reference-Cited by-同舟云学术

Optimal Chemotherapy for Women With Breast Cancer: The Plot Thickens

Published:2003-03-15 Issue:6 Volume:21 Page:963-964
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Pater Joseph L.¹,Pritchard Kathleen I.¹

Affiliation:

1. National Cancer Institute of Canada Clinical Trials Group, Queen’s University, Kingston, Ontario, Canada; Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.12.067

Reference9 articles.

1. Tamoxifen for early breast cancer: an overview of the randomised trials

2. Polychemotherapy for early breast cancer: an overview of the randomised trials

3. Nolvadex Adjuvant Trial Organisation: Controlled trial of tamoxifen as adjuvant agent in management of early breast cancer: Interim analysis at four years. Lancet 1:257,1983–261,

4. Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

5. Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequenced Compared With Simultaneous Anthracycline and Cyclophosphamide in High-Risk Stage I and II Breast Cancer: Final Analysis From INT-0137 (S9313);Journal of Clinical Oncology;2007-02-09

2. Topoisomerase IIα Gene Amplification and Response to Anthracycline-Containing Adjuvant Chemotherapy in Breast Cancer;Journal of Clinical Oncology;2006-06-01

3. Progesterone-Independent Effects of Human Progesterone Receptors (PRs) in Estrogen Receptor-Positive Breast Cancer: PR Isoform-Specific Gene Regulation and Tumor Biology;Molecular Endocrinology;2005-03-01

4. Taxanos en el tratamiento adyuvante del cáncer de mama con ganglios positivos: metanálisis;Farmacia Hospitalaria;2005-01

5. Comparing breast cancer mortality rates before-and-after a change in availability of screening in different regions: Extension of the paired availability design;BMC Medical Research Methodology;2004-05-18